Astaxanthin-loaded brain-permeable liposomes for Parkinson’s disease treatment via antioxidant and anti-inflammatory responses
Abstract Parkinson’s disease is a neurodegenerative disorder characterized by cardinal motor symptoms resulting from the loss of dopaminergic neurons in the substantia nigra pars compacta. Although current medications may alleviate its symptoms, Parkinson’s disease remains incurable. Astaxanthin is...
Saved in:
Main Authors: | Thai-Duong Nguyen, Shristi Khanal, Eunhee Lee, Jinsol Choi, Ganesh Bohara, Nikesh Rimal, Dong-Young Choi, Soyeun Park |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | Journal of Nanobiotechnology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12951-025-03104-8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Compensatory synaptotagmin-11 expression conceals parkinson’s disease-like phenotypes in parkin knockout mice
by: Nan Dong, et al.
Published: (2025-02-01) -
Astaxanthin relieves HT22 cells from LPS-induced inflammation and apoptosis by inhibiting oxygen species and regulating the TLR4/MyD88/NFκB signaling pathway
by: Tan Wang, et al.
Published: (2025-02-01) -
Liposome-like encapsulation of fish oil-based self-nano emulsifying formulation for improved bioavailability
by: Iqbal Ahmad, et al.
Published: (2025-06-01) -
Novel therapy modalities combining photodynamic therapy and liposomal cisplatin for pancreatic cancer treatments
by: Jia-Haur Chen, et al.
Published: (2025-03-01) -
Phytomedicine nanoformulations for Parkinson's disease
by: Chinthu V. Saji, et al.
Published: (2025-02-01)